Sudhir Sahasrabudhe
Director/Miembro de la Junta en Utah State University Foundation .
Cargos activos de Sudhir Sahasrabudhe
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Utah State University Foundation | Director/Miembro de la Junta | - | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Historial de carrera de Sudhir Sahasrabudhe
Antiguos cargos conocidos de Sudhir Sahasrabudhe.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MYRIAD GENETICS, INC. | Director Técnico/Científico/I+D | - | - |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Director Técnico/Científico/I+D | - | - |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Director Ejecutivo | 01/01/2001 | - |
Director Técnico/Científico/I+D | 01/01/2001 | - |
Formación de Sudhir Sahasrabudhe.
University of Baroda | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
India | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Utah State University Foundation |
- Bolsa de valores
- Insiders
- Sudhir Sahasrabudhe
- Experiencia